Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
Crossref DOI link: https://doi.org/10.1007/s10198-017-0907-5
Published Online: 2017-05-31
Published Print: 2018-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Grau, Santiago
Cámara, Rafael
Jurado, Manuel
Sanz, Jaime
Aragón, Belén
Gozalbo, Irmina
Funding for this research was provided by:
Merck Sharp and Dohme
License valid from 2017-05-31